Valuation : Tofflon Science and Technology Group Co., Ltd.

Market Cap 10.62B 1.58B 1.36B 1.28B 1.17B 2.18B 150B 2.19B 15.17B 5.87B 76.68B 5.94B 5.81B 244B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 7.21B 1.07B 923M 869M 793M 1.48B 102B 1.49B 10.29B 3.98B 52.03B 4.03B 3.94B 166B EV / Sales 2026 *
1.27x
EV / Sales 2027 * 1.52x
Free-Float
25.51%
Yield 2026 *
0.93%
Yield 2027 * 1.58%
08-28 Tofflon Science and Technology Group Co., Ltd. Proposes Interim Cash Dividend on A Shares for the First Half of 2026, Payable on 10 September 2026 CI
08-27 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
05-25 Tofflon Science and Technology Group Co., Ltd. Announces 2025 Final Profit Distribution Plan on A Shares, Payable on June 1, 2026 CI
04-28 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-28 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
25-10-28 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-09-16 Tofflon Science and Technology Group Co., Ltd. Approves Interim Cash Dividend on A Shares for the Year 2025, Payable on September 25, 2025 CI
25-08-28 Tofflon Science and Technology Group Co., Ltd. Proposes Interim Cash Dividend for the Year 2025 CI
25-08-27 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-06-12 Tofflon Science and Technology Group Co., Ltd.(SZSE:300171) dropped from Shenzhen Stock Exchange Component A Share Index CI
25-06-12 Tofflon Science and Technology Group Co., Ltd.(SZSE:300171) dropped from Shenzhen Stock Exchange Component Index CI
25-05-21 Tofflon Science and Technology Group Co., Ltd. Approves Cash Dividend on Share A for 2024 CI
25-04-25 Tofflon Science and Technology Group Co., Ltd. Proposes Final Cash Dividend for the Year 2024 CI
1 day+1.45%
1 week-6.87%
Current month-6.87%
1 month+8.55%
3 months+23.21%
6 months-15.29%
Current year-11.08%
1 week 13.69
Extreme 13.69
14.95
1 month 12.9
Extreme 12.9
15.88
Current year 10.42
Extreme 10.42
20.37
1 year 10.42
Extreme 10.42
20.37
3 years 9.6
Extreme 9.6
20.37
5 years 9.6
Extreme 9.6
57.5
10 years 5.16
Extreme 5.16
68
Manager TitleAgeSince
Chief Executive Officer 62 1992-12-31
Director of Finance/CFO 45 2012-06-30
Corporate Officer/Principal 57 2000-12-31
Director TitleAgeSince
Chairman 62 2008-02-29
Director/Board Member 54 2008-03-29
Director/Board Member 53 2008-03-29
Date Insider Type Main position Quantity % Market Cap. Importance
2/5/24 Buy

Chief Executive Officer

40,000 0.0072%
2/1/24 Buy

Chief Executive Officer

30,000 0.0054%
1/17/24 Buy

Chief Executive Officer

80,000 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
+1.45%-6.87%-1.62%-24.05% 1.56B
-0.70%+0.40%+25.74%+133.59% 121B
+0.69%-2.32%+40.12%+43.59% 36.36B
-1.50%-2.95%+35.99%+73.48% 31.12B
-1.64%+0.63%-6.56%+8.20% 29.63B
+2.38%-3.34%+52.66%-2.99% 27.95B
+0.96%+2.53%+9.40%+37.03% 25.98B
+2.95%+1.80%-22.30%+14.27% 24.68B
+0.82%-1.95%+29.95%+45.63% 24.09B
+0.56%-4.97%+465.56%+1,837.83% 24.88B
Average +0.67%-2.21%+62.89%+216.66% 34.76B
Weighted average by Cap. +0.19%-2.41%+54.59%+196.62%

Financials

2026 *2027 *
Net sales 5.67B 845M 727M 684M 624M 1.16B 80.15B 1.17B 8.1B 3.13B 40.96B 3.17B 3.11B 130B 6.24B 929M 799M 752M 686M 1.28B 88.12B 1.29B 8.91B 3.45B 45.04B 3.49B 3.41B 143B
Net income - -
Net Debt -3.41B -509M -437M -412M -376M -701M -48.23B -705M -4.88B -1.89B -24.65B -1.91B -1.87B -78.45B -1.15B -171M -147M -138M -126M -236M -16.22B -237M -1.64B -635M -8.29B -643M -629M -26.39B
Logo Tofflon Science and Technology Group Co., Ltd.
Tofflon Science and Technology Group Co Ltd is a China-based company mainly engaged in the research, development, production, and sales of pharmaceutical equipment, and the provision of technical services. The Company mainly operates four businesses. The bioprocessing business mainly provides equipment, instruments, and consumables such as fermentation systems, precision packaging systems, and traditional Chinese medicine extraction systems. The pharmaceutical preparations business mainly provides equipment and instruments required for the preparation of injectable dosage forms, oral solid dosage forms, and the inspection and packaging of finished drugs. The integrated engineering solutions business mainly provides information system software and intelligent manufacturing integrated solutions. The food engineering business is mainly engaged in the manufacturing of equipment for the liquid food sector, and the provision of system solutions, process engineering, and overall solutions.
Employees
5,479
Date Price Change Volume
26-09-08 CN¥13.96 +1.45% 11,304,500
26-09-07 CN¥13.76 -1.92% 9,637,590
26-09-04 CN¥14.03 -0.99% 10,997,659
26-09-03 CN¥14.17 -1.46% 12,762,669
26-09-02 CN¥14.38 -4.32% 14,834,141
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
13.96CNY
Average target price
17.00CNY
Spread / Average Target
+21.78%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300171 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!